Cargando…
Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
Somatic gene editing (SGE) holds great promise for making genetic therapy possible for many monogenic conditions very soon. Is our current system of European market authorization and reimbursement ready for the expected tsunami of gene therapies? At a recent workshop of the Netherlands ZonMw consort...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484669/ https://www.ncbi.nlm.nih.gov/pubmed/33850300 http://dx.doi.org/10.1038/s41431-021-00877-y |